Technological Innovation in Health Care and the Long-Term Fiscal Outlook
Technological Innovation in Health Care and the Long-Term Fiscal Outlook
批准号:
8750769
负责人:
DANA P GOLDMAN
金额:
$39.97万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-15 至 2016-06-30
关键词:
AccountingAgeAgingAmericanBehavioralBehavioral ModelBudgetsCaringComplementDiseaseEconomic ModelsEconomicsElderlyEquilibriumEvolutionFeedbackFutureGenerationsGovernmentGrowthHealthHealth Care CostsHealth PolicyHealthcareHeartIncomeInsuranceKnowledgeLabor ForcesLifeLiteratureLongevityMapsMedicalMedical TechnologyMedicareMedicare/MedicaidModelingOutcomePast TrendsPharmacologic SubstancePoliciesPopulationPopulation GrowthPriceProductionResearchRoleRunningScientific Advances and AccomplishmentsSocial ValuesSocial WelfareStreamTechnologyTimeUnited StatesUnited States Centers for Medicare and Medicaid Servicesagedaging populationbasecosteconomic outcomefallsfunctional statusinnovationmodels and simulationmortalitypopulation healthprogramspublic health relevancesimulationtechnological innovationtrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over the past 50 years, longevity has risen at a steady pace. Functional status of the elderly has also witnessed important improvements, although gains have leveled off recently. These improvements do not come without costs. The United States has devoted an increasing share of its income to health care over that same period. In part because of the projected increase of health costs, the long-term fiscal outlook of the U.S. presents important challenges. Fiscal forecasts from the Congressional Budget Office and the Centers for Medicare & Medicaid Services (CMS) are dire, with Medicare spending alone projected to more than double as a share of national income, from 3.7% today to 7.3% in 2050. However, these forecasts take the driver of health care costs-technology-as exogenous, or fixed. This is unrealistic. We know innovators maximize the expected value of a future profit stream, and they will take into account the demand for their innovations in the future. The proposed research will marry two distinct but complementary approaches from the health policy and macroeconomic fields. First, we will incorporate technological change, and its determinants, into existing models projecting the long- term fiscal outlook of the U.S. Our engine will be an economic-demographic microsimulation that covers the population aged 25 and older, the Future Americans Model (FAM). This approach will examine granular technological change to understand consequences for spending and population health. Second, we will build a macroeconomic growth model to understand endogenous innovation and health care spending in overlapping generations (OLG) that incorporates the projections of our economic-demographic simulation. Such OLG models have proven very useful for understanding long-run economic outcomes and their effects on government debt. Results from the OLG model will complement the results of the FAM by revealing the fiscal paths consistent with a balanced government budget when taking behavioral and macroeconomic changes into account. There are four principal outcomes of this project. First, we will quantify the fiscal consequences of various innovation scenarios. Second, the research will identify scenarios under which new innovations will impact health by effectively treating one disease while simultaneously impacting innovation for other diseases. Third, the project will identify scenarios under which health spending would rise or fall in future years as a result of technological change and how health spending can be financed with minimum welfare consequences using the FAM-calibrated OLG model. Fourth, by combining behavioral models with simulation models such as the Future Americans Model, this project will advance the state of knowledge on the possibilities of combining different approaches to make long-term fiscal forecasts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
-
批准号:10216946
-
项目类别:
-
资助金额:$8.55万
-
财政年份:2020
-
负责人:DANA P GOLDMAN
-
依托单位:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
-
批准号:10417203
-
项目类别:
-
资助金额:$8.11万
-
财政年份:2020
-
负责人:DANA P GOLDMAN
-
依托单位:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
-
批准号:10657377
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2020
-
负责人:DANA P GOLDMAN
-
依托单位:
Precision Medicine: Moving Theory into Practice
-
批准号:9752826
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2019
-
负责人:DANA P GOLDMAN
-
依托单位:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
-
批准号:9977782
-
项目类别:
-
资助金额:$54.69万
-
财政年份:2018
-
负责人:DANA P GOLDMAN
-
依托单位:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
-
批准号:10176332
-
项目类别:
-
资助金额:$54.29万
-
财政年份:2018
-
负责人:DANA P GOLDMAN
-
依托单位:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
-
批准号:9789172
-
项目类别:
-
资助金额:$61.65万
-
财政年份:2018
-
负责人:DANA P GOLDMAN
-
依托单位:
The Long-Term Benefits of Interventions to Improve T2D Outcomes
-
批准号:9176837
-
项目类别:
-
资助金额:$69.01万
-
财政年份:2016
-
负责人:DANA P GOLDMAN
-
依托单位:
The Long-Term Benefits of Interventions to Improve T2D Outcomes
-
批准号:9321379
-
项目类别:
-
资助金额:$65.95万
-
财政年份:2016
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8987153
-
项目类别:
-
资助金额:$8.44万
-
财政年份:2015
-
负责人:DANA P GOLDMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8395435
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8374285
-
项目类别:
-
资助金额:$57.21万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8535592
-
项目类别:
-
资助金额:$51.34万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8688127
-
项目类别:
-
资助金额:$52.82万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
The Science of Alzheimer's Disease and Related Dementias
-
批准号:9927447
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
RCMAR - Administrative Core
-
批准号:10451545
-
项目类别:
-
资助金额:$18.99万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:9982152
-
项目类别:
-
资助金额:$54.43万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8896384
-
项目类别:
-
资助金额:$51.3万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
RCMAR - Administrative Core
-
批准号:10218034
-
项目类别:
-
资助金额:$18.99万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
COMMUNITY LIAISON CORE
-
批准号:8395437
-
项目类别:
-
资助金额:$25.07万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: